Patients with PNH and impaired bone marrow function showed benefits in haematological and clinical parameters in response to pegcetacoplan, in particular improvements in Hb, LDH, ARC, and FACIT-Fatigue scores at week 16 in PEGASUS and week 26 in PRINCE. Here, GSTM1 is linked to paroxysmal nocturnal hemoglobinuria.